Hepatic Cell News 2.04 February 2, 2018 | |
| |
TOP STORYNon-Parenchymal TREM-2 Protects the Liver from Immune-Mediated Hepatocellular Damage Scientists hypothesized that the anti-inflammatory effects of triggering receptor expressed on myeloid cells 2 (TREM-2) on toll-like receptor signaling may limit hepatic injury. TREM-2 was expressed on non-parenchymal hepatic cells and induced during liver injury in mice and man. Liver damage in Trem–2-/- mice following chronic injury and acetaminophen challenge was associated with elevated hepatic lipid peroxidation and macrophage content. [Gut] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Circular RNA cSMARCA5 Inhibits Growth and Metastasis in Hepatocellular Carcinoma The role of cSMARCA5 in hepatocellular carcinoma progression was assessed both in vitro and in vivo. Mechanistically, the authors found that cSMARCA5 could promote the expression of TIMP3, a well-known tumor suppressor, by sponging miR-17-3p and miR-181b-5p. [J Hepatol] Abstract Interleukin-1 receptor type 1 (IL-1RI) during acute liver failure (ALF) was investigated using a novel transgenic mouse model exhibiting deletion of all signaling-capable IL-1R isoforms in hepatocytes. IL-1RI in hepatocytes played a pivotal role in an IL-1-driven auto-amplification of cell death and inflammation in the onset of ALF. [J Hepatol] Abstract Hepatic hexokinase (HK2) deletion inhibited tumor incidence in a mouse model of hepatocarcinogenesis. Silencing HK2 in human hepatocellular carcinoma cells inhibited tumorigenesis and increased cell death, which could not be restored by glucokinase or mitochondrial binding deficient HK2. [Nat Commun] Full Article | Press Release Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders Researchers report that tumor progression locus 2 (TPL2) protein expression was significantly increased in fatty liver from diverse species, including humans, monkeys and mice. Further investigations revealed that compared to wild-type littermates, hepatocyte-specific TPL2 knockout mice exhibited improved lipid and glucose imbalance, reserved insulin sensitivity and alleviated inflammation in response to high-fat diet feeding. [Hepatology] Abstract Investigators present in vivo evidence that Pin1 overexpression is directly linked to the development of hepatocellular carcinoma (HCC). Administration with Pin1 inhibitor API-1, a novel and specific small molecule targeting Pin1 PPIase domain and inhibiting Pin1 cis–trans isomerizing activity, suppressed in vitro cell proliferation and migration of HCC cells. [Hepatology] Abstract The authors found that KIF4A expression was upregulated in hepatocellular carcinoma (HCC) based on a meta-analysis of Oncomine database. They further confirmed that both KIF4A mRNA and protein expressions were overexpressed in human HCC tumor tissues as well as cancer cell lines. [Cell Death Dis] Full Article Using in vitro and in vivo assays, scientists demonstrated that ubiquitin-specific protease 4 (USP4) overexpression enhanced hepatocellular carcinoma (HCC) cell growth, migration, and invasion. Mechanistically, cyclophilin A was identified as an important molecule for USP4-mediated oncogenic activity in HCC. [Cell Death Dis] Full Article Implication of trans-11,trans-13 Conjugated Linoleic Acid in the Development of Hepatic Steatosis In mice with depleted n-3 polyunsaturated fatty acids, researchers observed an accumulation of trans-11,trans-13 CLA and cis-9,cis-11 conjugated linoleic acids in the liver tissue that were associated with an increased triglyceride content and expression of lipogenic genes. They used an in vitro model to evaluate the impact of these two conjugated linoleic acids on hepatic lipid metabolism. [PLoS One] Full Article | |
| |
REVIEWSThe Immunology of Hepatocellular Carcinoma The authors summarize the roles of specific immune cell subsets in chronic liver disease, with a focus on non-alcoholic steatohepatitis and hepatocellular carcinoma . [Nat Immunol] Abstract Visit our reviews page to see a complete list of reviews in the hepatic cell research field. | |
| |
INDUSTRY NEWSFirst John W. Walsh Translational Research Award Granted The Alpha-1 Foundation celebrated the first granting of the John W. Walsh Translational Research Award in Alpha-1 Antitrypsin Deficiency. The award was granted to Joseph Kaserman, MD, instructor of medicine at Boston University School of Medicine and a physician in Pulmonary, Allergy, Sleep and Critical Care Medicine at Boston Medical Center. [Alpha-1 Foundation] Press Release Varian Signs Agreement to Acquire Sirtex Varian Medical Systems announced it has signed an agreement to acquire all the outstanding shares of Sirtex Medical Limited, an Australia-based global life sciences company focused on interventional oncology therapies. [Varian Medical Systems] Press Release | |
| |
POLICY NEWSBulgaria in the Cold as European Union Freezes Its Funding European Union science ministers are due to meet in their bloc’s poorest member state — Bulgaria — to discuss future EU research policy. For the host nation, it was supposed to be a chance to showcase its ambitious plans to boost economic growth by attracting international research institutes to the country. [Nature News] Editorial UK Doctors Select First Women to Have ‘Three-Person Babies’ Doctors in Newcastle have been granted permission to create Britain’s first “three-person babies” for two women who are at risk of passing on devastating and incurable genetic diseases to their children. [The Guardian] Editorial Kid Co-Authors in South Korea Spur Government Probe The South Korean government is expanding an investigation into researchers who named their children as co-authors on papers. The extended probe comes after a government report identified 82 academic papers on which authors had named their children or relatives — many of them in middle or high school — as co-authors on the publications. [Nature News] Editorial
| |
EVENTSNEW Stem Cells in Disease Modelling and Drug Discovery (SCDMDD) 2018 Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW PhD Student – Hepatic Endothelial Heterogeneity (German Cancer Research Center) Postdoctoral Fellow – Liver Cancer Research (University of California, San Francisco) Locum Chief Editor – Nature Reviews Gastroenterology & Hepatology (Nature Research) Postdoctoral Position – Liver Diseases (University of Illinois) Part-Time Postdoctoral Scientist – HCV Vaccine Model Development (University of Oxford) Postdoctoral Fellow – Liver Cancer (University Health Network) Postdoctoral Scholar Position – Cancer & Stem Cell Epigenomics (University of California, Davis) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Hepatic Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|